Echo IQ’s EchoSolv AS Cleared by FDA for US Market

EchoIQ Limited (AU:EIQ) has released an update.

Echo IQ Limited has announced a significant development as their AI-driven EchoSolv AS has received FDA clearance, enabling its use in the US healthcare market. The company is actively discussing the implementation of EchoSolv AS with US healthcare providers, and it is also working to secure reimbursement codes to facilitate its adoption. Additionally, Echo IQ is finalizing the appointment of a new CEO to lead the expansion in the US following a successful capital raise aimed at commercialization and product development efforts.

For further insights into AU:EIQ stock, check out TipRanks’ Stock Analysis page.